A leap beyond the visible with OCULUS Pentacam® Cornea OCT

https://www.main-line.co.uk/wp-content/uploads/OCULUS-OCT-article-images-17.jpg This autumn, OCULUS is launching the Pentacam® Cornea OCT, a novel imaging technology that promises to enhance corneal diagnostics. Initial studies demonstrate its impressive accuracy and clinical potential. A recent peer-reviewed paper highlights how this device uniquely combines ultra-high-resolution spectral domain optical coherence tomography (SD-OCT) with Scheimpflug photography, offering unprecedented insights into corneal structures. The Pentacam® Cornea OCT is garnering attention from eye care professionals worldwide due to its distinctive features. But what exactly sets this technology apart?

What makes the Pentacam® Cornea OCT stand out?

Superior Resolution With an axial resolution below 1.9 μm in corneal tissue, this device provides incredibly detailed images of corneal layers. This level of precision allows for what researchers are calling an “optical biopsy” – a non-invasive way to examine corneal structures at a near-cellular level. Innovative Dual Technology By merging SD-OCT with Scheimpflug photography, the Pentacam® Cornea OCT offers a synergistic approach to corneal imaging. While OCT excels at revealing fine structural details, Scheimpflug imaging is particularly adept at detecting light scattering, making it easier to identify opacities and other abnormalities. Comprehensive Coverage Thanks to its novel wide-angle pericentric scan system, this device can image the entire width of the cornea, including the often tricky limbal regions. This comprehensive view is crucial for detecting conditions that may manifest in the corneal periphery. Rapid Acquisition In just 1.1 seconds, the Pentacam® Cornea OCT captures 25 OCT B-Scans and 25 Scheimpflug images. This speed minimizes motion artifacts and patient discomfort, ensuring high-quality images even in challenging clinical scenarios. Clinical Applications The potential applications of this technology are vast. In this month’s published study  by Dr. Renato Ambrósio Jr et alia, researchers demonstrated its effectiveness in imaging various corneal pathologies, including:

• Cogan dystrophy
• Post-COVID-19 corneal fibrosis
• Fuchs’ endothelial dystrophy with keratoconus
• Intracorneal ring segments
• Lattice corneal dystrophy
• Pressure-induced stromal keratitis (PISK)
• Salzmann’s nodular degeneration

Perhaps most excitingly, the Pentacam® Cornea OCT shows promise in the early detection of ectatic corneal diseases like keratoconus. This could be groundbreaking for refractive surgery screening, potentially reducing the risk of post-LASIK ectasia. The future of corneal diagnostics As we look to the future, the possibilities are intriguing. The authors suggest that further studies could explore how different wavelengths might provide even more diagnostic information. There’s also potential for integrating artificial intelligence to enhance disease detection and risk assessment. In conclusion, the Pentacam® Cornea OCT represents a significant leap forward in corneal imaging technology. By providing unprecedented detail and resolution, it enables a level of corneal examination that was previously impossible without invasive procedures. As this technology becomes more widely available, it has the potential to improve our understanding of corneal pathologies and enhance patient care in ophthalmology practices worldwide. Want to learn more? The full paper, “Combined Rotating Ultra-High-Resolution Spectral Domain OCT and Scheimpflug Imaging for In Vivo Corneal Optical Biopsy,” authored by Dr. Renato Ambrósio Jr. and colleagues, is now available for download. Don’t miss this opportunity to dive deep into the future of corneal diagnostics! Download Full Paper